t: +44 (0) 1727 809917

e: info@healthcare-ed.com

web stats

Oncology Trials: Focus on Phase III

29-30 Nov 2017 London, UK Price: GBP 2,880 (+VAT/Taxes)

Registration advised by: Monday 23rd October 2017

What is Oncology: Phase III Trials?

Oncology: Phase III Trials is a two-day, rapid and progressive training programme.  Led by specialist physicians face-to-face learning equips delegates with the knowledge required to discuss Oncology Trials confidently and credibly.

Oncology: Phase III Trials is a high calibre, two-day training programme presented in London, UK. This interactive and informative course provides a comprehensive overview of the planning and implementation of oncology clinical trials, focusing on Phase III. The course will demonstrate how oncology trials differ in design and conduct from those in other therapy areas. Delegates learn to design trials to minimise the deficiencies that lead to inappropriate interpretation whilst maximising the competitive advantage. Delegates will hear the perspective of currently practicing oncologists with extensive experience of industry clinical trials as well as professionals who will discuss oncology clinical trial statistics and oncology product market entry.

What will I learn about oncology clinical trials?

You have the opportunity to learn from experts:

  • How oncology trials differ in design and conduct from those in other therapy areas
  • How to design trials to minimise the deficiencies that lead to inappropriate interpretation whilst maximising the competitive advantage
  • Practicing oncologists with extensive experience of industry clinical trials & professionals discuss oncology clinical trial statistics and oncology product market entry

Topics include:

  • Introduction to oncology clinical trial design and planning
  • Informed consent/patient information
  • The impact of trials on clinical practice
  • Statistical analysis and reporting
  • Health economics assessment
  • Quality of life assessment

Faculty includes:
Professor Allan Hackshaw, Deputy Director, Cancer Research UK & UCL Cancer Trials Centre, Cancer Institute, University College London, London, UK
Mr Jim Furniss
, SVP, Global Market Access, GfK Market Access, UK
Professor Chris Twelves
, Professor of Clinical Pharmacology and Oncology, St James’s Institute of Oncology, UK

Is this oncology clinical trials course for me?

Oncology: Phase III Trials is ideal for pharmaceutical, medical technology and biotechnology industry personnel working in the area of oncology. It is appropriate for those involved in clinical research, medical affairs and regulatory functions, as well as individuals in strategic marketing and business functions.

2880